Cargando…
P687: EARLY RESULTS OF A PHASE II STUDY EVALUATING THE ADDITION OF ASCIMINIB TO ERADICATE MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429707/ http://dx.doi.org/10.1097/01.HS9.0000969652.20441.1b |
| _version_ | 1785090779562115072 |
|---|---|
| author | Bidikian, Aram Short, Nicholas Ganesh, Ramya Pike, Allison Sasaki, Koji Jabbour, Elias Andreeff, Michael Cortes, Jorge Issa, Ghayas |
| author_facet | Bidikian, Aram Short, Nicholas Ganesh, Ramya Pike, Allison Sasaki, Koji Jabbour, Elias Andreeff, Michael Cortes, Jorge Issa, Ghayas |
| author_sort | Bidikian, Aram |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429707 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104297072023-08-17 P687: EARLY RESULTS OF A PHASE II STUDY EVALUATING THE ADDITION OF ASCIMINIB TO ERADICATE MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA Bidikian, Aram Short, Nicholas Ganesh, Ramya Pike, Allison Sasaki, Koji Jabbour, Elias Andreeff, Michael Cortes, Jorge Issa, Ghayas Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429707/ http://dx.doi.org/10.1097/01.HS9.0000969652.20441.1b Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Bidikian, Aram Short, Nicholas Ganesh, Ramya Pike, Allison Sasaki, Koji Jabbour, Elias Andreeff, Michael Cortes, Jorge Issa, Ghayas P687: EARLY RESULTS OF A PHASE II STUDY EVALUATING THE ADDITION OF ASCIMINIB TO ERADICATE MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA |
| title | P687: EARLY RESULTS OF A PHASE II STUDY EVALUATING THE ADDITION OF ASCIMINIB TO ERADICATE MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA |
| title_full | P687: EARLY RESULTS OF A PHASE II STUDY EVALUATING THE ADDITION OF ASCIMINIB TO ERADICATE MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA |
| title_fullStr | P687: EARLY RESULTS OF A PHASE II STUDY EVALUATING THE ADDITION OF ASCIMINIB TO ERADICATE MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA |
| title_full_unstemmed | P687: EARLY RESULTS OF A PHASE II STUDY EVALUATING THE ADDITION OF ASCIMINIB TO ERADICATE MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA |
| title_short | P687: EARLY RESULTS OF A PHASE II STUDY EVALUATING THE ADDITION OF ASCIMINIB TO ERADICATE MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA |
| title_sort | p687: early results of a phase ii study evaluating the addition of asciminib to eradicate minimal residual disease in chronic myeloid leukemia |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429707/ http://dx.doi.org/10.1097/01.HS9.0000969652.20441.1b |
| work_keys_str_mv | AT bidikianaram p687earlyresultsofaphaseiistudyevaluatingtheadditionofasciminibtoeradicateminimalresidualdiseaseinchronicmyeloidleukemia AT shortnicholas p687earlyresultsofaphaseiistudyevaluatingtheadditionofasciminibtoeradicateminimalresidualdiseaseinchronicmyeloidleukemia AT ganeshramya p687earlyresultsofaphaseiistudyevaluatingtheadditionofasciminibtoeradicateminimalresidualdiseaseinchronicmyeloidleukemia AT pikeallison p687earlyresultsofaphaseiistudyevaluatingtheadditionofasciminibtoeradicateminimalresidualdiseaseinchronicmyeloidleukemia AT sasakikoji p687earlyresultsofaphaseiistudyevaluatingtheadditionofasciminibtoeradicateminimalresidualdiseaseinchronicmyeloidleukemia AT jabbourelias p687earlyresultsofaphaseiistudyevaluatingtheadditionofasciminibtoeradicateminimalresidualdiseaseinchronicmyeloidleukemia AT andreeffmichael p687earlyresultsofaphaseiistudyevaluatingtheadditionofasciminibtoeradicateminimalresidualdiseaseinchronicmyeloidleukemia AT cortesjorge p687earlyresultsofaphaseiistudyevaluatingtheadditionofasciminibtoeradicateminimalresidualdiseaseinchronicmyeloidleukemia AT issaghayas p687earlyresultsofaphaseiistudyevaluatingtheadditionofasciminibtoeradicateminimalresidualdiseaseinchronicmyeloidleukemia |